TICKERNOMICS Sign up
Last Update: 2023-12-23 06:00:36
IRADIMED CORP ( IRMD ) https://www.iradimed.com
45.94USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
IRMD
64.67%
SPY
30.72%
IRMD
107.19%
SPY
112.82%
IRMD
136.12%
SPY
201.04%
IRMD
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
568.53
523.93
0.03
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
34.82
9.03
7.62
1.70
0.34
26.07
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
35.78
77.78
31.92
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.7516
21.32
27.16
0.94
Other Earnings and Cash Flow Stats:
IRADIMED CORP ( IRMD ) Net Income TTM ($MM) is 15.57
IRADIMED CORP ( IRMD ) Operating Income TTM ($MM) is 18.30
IRADIMED CORP ( IRMD ) Owners' Earnings Annual ($MM) is 0.00
IRADIMED CORP ( IRMD ) Current Price to Owners' Earnings ratio is 0.00
IRADIMED CORP ( IRMD ) EBITDA TTM ($MM) is 19.52
IRADIMED CORP ( IRMD ) EBITDA Margin is 31.92%
Capital Allocation:
IRADIMED CORP ( IRMD ) has paid 0.15 dividends per share and bought back -0.104708 million shares in the past 12 months
IRADIMED CORP ( IRMD ) has reduced its debt by 0.129972 million USD in the last 12 months
Capital Structure:
IRADIMED CORP ( IRMD ) Interest-bearing Debt ($MM) as of last quarter is 2
IRADIMED CORP ( IRMD ) Annual Working Capital Investments ($MM) are -38
IRADIMED CORP ( IRMD ) Book Value ($MM) as of last quarter is 74
IRADIMED CORP ( IRMD ) Debt/Capital as of last quarter is 2%
Other Balance Sheet Stats:
IRADIMED CORP ( IRMD ) has 46 million in cash on hand as of last quarter
IRADIMED CORP ( IRMD ) has 7 million of liabilities due within 12 months, and long term debt 0 as of last quarter
IRADIMED CORP ( IRMD ) has 12 common shares outstanding as of last quarter
IRADIMED CORP ( IRMD ) has 0 million USD of preferred stock value
Academic Scores:
IRADIMED CORP ( IRMD ) Altman Z-Score is 29.64 as of last quarter
IRADIMED CORP ( IRMD ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
IRADIMED CORP ( IRMD ) largest shareholder is Acadian Asset Management LLC owning 181783 shares at 8.35 ($MM) value
James B Hawkins(an insider) Sold 4277 shares of IRADIMED CORP ( IRMD ) for the amount of $190668.66 on 2023-12-14
42.74% of IRADIMED CORP ( IRMD ) is held by insiders, and 47.65% is held by institutions
IRADIMED CORP ( IRMD ) went public on 2014-07-16
Other IRADIMED CORP ( IRMD ) financial metrics:
FCF:10.30
Unlevered Free Cash Flow:0.00
EPS:1.59
Operating Margin:35.78
Gross Profit Margin:77.78
Div. Payout Ratio%:11.70
Div. Growth YoY%:-85.00
Equity Return%:27.18
Beta:0.94
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About IRADIMED CORP ( IRMD ) :
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.